hypoparathyroidism: Hypoparathyroidism is is an endocrine disorder in which the parathyroid glands in the neck do not produce enough parathyroid hormone (PTH). Common signs and symptoms includeabdominal pain, brittle nails, cataracts, dry hair and skin,muscle cramps,tetany, pain in the face, legs, and feet, seizures, tingling sensation,and weakened tooth enamel (in children). It may be caused byinjury to the parathyroid glands (e.g., during surgery). Other causes, include low blood magnesium levels, a side effect of radioactive iodine treatment for hyperthyroidism , metabolic alkalosis , DiGeorge syndrome , and type I polyglandular autoimmune syndrome . The goal of treatment is to restore the calcium and mineral balance in the body.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
4 out of 7 registries used, show all original rules. |
1281 |
4. Check minimum number of events
Min. number of events
3
|
1281 |
5. Include endpointsNone |
1281 |
6. Filter based on genotype QC (FinnGen only) |
1281 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E20-E35
- Name in latin
- Hypoparathyreoidismus
Similar endpoints
↥List of similar endpoints to
Hypoparathyroidism
based on the number of shared cases.
Similar with more cases:
- Disorders of parathyroid gland
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8240 | 6591 | 1583 |
| Only index persons | 6794 | 5561 | 1233 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.19 | 0.04 |
| Only index persons | 0.18 | 0.20 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 60.83 | 61.53 | 57.93 |
| Only index persons | 60.57 | 61.51 | 56.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1281 | 1016 | 265 |
| Unadjusted period prevalence (%) | 0.30 | 0.35 | 0.12 |
| Median age at first event (years) | 59.38 | 59.35 | 59.53 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1117
- Matched controls
- 11172
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
318
Kela drug reimbursment
Teriparatide
2054.5
323.0
475
*
106
Kela drug reimbursment
Hypoparathyroidism
+∞
323.0
453
*
H05AA02
ATC
teriparatide; parenteral
4666.4
323.0
473
*
A11CC03
ATC
alfacalcidol; systemic
77.3
321.6
359
68
A12AA04
ATC
calcium carbonate; oral
99.7
288.5
311
43
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
675.8
229.3
219
*
A11CC02
ATC
dihydrotachysterol; oral
600.3
207.0
199
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.1
193.6
823
3160
104
Kela drug reimbursment
Thyroid insufficiency
9.7
167.0
382
568
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
37.2
162.8
210
69
M05BX04
ATC
denosumab; parenteral
12.8
161.3
309
325
E83.51
ICD-10 Finland
Hypocalcemia
138.2
147.4
155
13
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
1576.1
145.1
138
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.7
144.6
304
377
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
104.2
141.3
153
17
A12AA06
ATC
calcium lactate gluconate; oral
1455.3
135.3
129
*
BAA60
NOMESCO Finland
Total thyroidectomy
19.4
125.8
197
122
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
19.6
122.7
191
116
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
23.8
116.1
169
83
H03AA01
ATC
levothyroxine sodium; systemic
4.5
111.1
554
2019
M05BA04
ATC
alendronic acid; oral
6.7
109.2
316
622
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
36.5
109.2
141
44
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
19.3
108.3
169
102
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
39.9
108.2
137
39
L95
ICPC
Osteoporosis
12.0
99.8
192
190
E20.0
ICD-10 Finland
Idiopathic hypoparathyroidism
1023.6
97.5
94
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
+∞
97.3
92
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
182.8
96.9
100
6
M81.9
ICD-10 Finland
Osteoporosis, unspecified
9.0
87.8
199
264
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.8
86.3
276
598
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
13.7
76.8
137
113
H02AB09
ATC
hydrocortisone; systemic
20.6
63.0
95
50
M05BA07
ATC
risedronic acid; oral
7.5
60.4
151
228
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
51.9
265
870
L04AX01
ATC
azathioprine; systemic
7.1
50.7
130
202
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.6
47.7
148
295
E21.0
ICD-10 Finland
Primary hyperparathyroidism
106.8
47.2
51
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
46.7
607
3598
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
234.2
44.3
45
*
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
51.1
41.0
49
10
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
39.6
226
792
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.4
38.4
121
244
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.6
38.3
191
603
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
6.9
38.2
99
155
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
37.8
441
2383
N02AX02
ATC
tramadol; systemic, rectal
2.3
37.5
543
3262
N02AA05
ATC
oxycodone; systemic
3.0
36.3
245
959
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
36.8
36.2
46
13
H02AB06
ATC
prednisolone; systemic
2.2
35.9
602
3843
C03CA01
ATC
furosemide; systemic
2.4
35.7
425
2304
E20.1
ICD-10 Finland
Pseudohypoparathyroidism
+∞
35.6
34
*
M05BB03
ATC
alendronic acid and colecalciferol; oral
6.5
35.3
95
157
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
48.4
34.9
42
9
E83.50
ICD-10 Finland
Hypercalcemia
17.5
34.9
55
33
P01BA02
ATC
hydroxychloroquine; oral
3.5
34.8
182
593
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
34.7
241
962
M81.4
ICD-10 Finland
Drug-induced osteoporosis
33.4
34.6
45
14
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
34.6
33
*
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
347.3
34.1
34
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.2
33.8
139
369
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.9
33.8
148
416
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
6.3
32.9
90
152
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.0
32.8
139
379
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
10.9
32.5
63
61
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
32.4
31
*
J01FF01
ATC
clindamycin; systemic
2.3
32.0
371
1959
NF1AA
NOMESCO Finland
Hip X-ray examination
3.3
31.5
173
582
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
54.6
31.5
37
7
M05BX03
ATC
strontium ranelate; oral
15.7
31.1
51
34
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
72.0
31.0
35
5
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
4.7
30.7
109
250
L88
ICPC
Rheumatoid/seropositive arthritis
4.8
30.6
106
237
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
30.4
398
2216
J01MA12
ATC
levofloxacin; systemic
2.6
30.2
267
1217
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
29.9
371
2013
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
29.5
221
913
E20
ICD-10 Finland
Hypoparathyroidism
+∞
29.3
28
*
M80
ICD-10 Finland
Osteoporosis with pathological fracture
12.6
29.0
52
43
ZX120
NOMESCO Finland
Intravenous
3.2
28.9
163
558
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
6.2
28.1
78
134
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.2
27.8
161
561
SPAT1262
SPAT
Handing over of treatment supplies
2.5
27.7
266
1261
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
36.1
27.5
35
10
L04AA13
ATC
leflunomide; oral
5.8
27.0
79
145
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
26.7
294
1490
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.9
26.7
77
139
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
26.6
293
1484
M05BA06
ATC
ibandronic acid; systemic
6.0
26.1
74
131
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
26.0
254
1209
N03AX16
ATC
pregabalin; oral
2.2
25.6
326
1767
L04AA01
ATC
[U] ciclosporin; systemic
10.4
25.4
50
50
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
25.4
148
517
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
25.2
194
810
L28
ICPC
Limited function/disability (L)
2.4
25.0
252
1219
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.0
24.8
531
3542
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
255.6
24.8
25
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
32.9
24.7
32
10
H02AB04
ATC
methylprednisolone; systemic
2.5
24.6
218
986
H02AB07
ATC
prednisone; oral
2.5
24.2
220
1008
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.1
23.9
144
514
L04AA06
ATC
mycophenolic acid; systemic
9.4
23.7
49
54
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
23.7
294
1566
SPAT1254
SPAT
Administration of medicine
2.5
23.7
219
1009
127
Kela drug reimbursment
Transplant complication
12.0
23.6
43
37
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.1
23.3
95
249
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
7.0
23.2
58
87
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.5
22.8
114
355
2506
FHL
Thyroidectomy
46.0
22.4
27
6
25219
ICD-8 Finland
Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD
+∞
21.9
21
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
21.9
126
435
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
21.7
177
761
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
31.9
21.5
28
9
SPAT1229
SPAT
Assessment of need for aid
2.9
21.5
143
541
N03AX12
ATC
gabapentin; oral
2.3
21.3
216
1038
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
5.2
21.3
67
135
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
21.2
135
499
A28
ICPC
Limited function/disability NOS
2.3
21.1
220
1073
A02BC02
ATC
pantoprazole; systemic
1.9
21.1
759
5934
2521A
ICD-9 Finland
Disorders of parathyroid gland, Hypoparathyroidism
+∞
20.9
20
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
20.3
154
632
M54.5
ICD-10 Finland
Low back pain
1.9
20.3
407
2594
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
20.3
241
1246
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
7.2
20.1
49
71
M81.8
ICD-10 Finland
Other osteoporosis
9.4
20.0
41
45
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
+∞
19.8
19
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
19.8
19
*
AA1AD
NOMESCO Finland
CT of head and brain
2.0
19.8
302
1732
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
19.6
199
955
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
25.1
19.6
27
11
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
9.8
19.5
39
41
L04AD01
ATC
ciclosporin; systemic
7.0
19.4
48
71
R50.9
ICD-10 Finland
Fever, unspecified
2.4
19.4
176
797
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
19.4
217
1091
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
7.6
19.3
45
61
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
19.3
382
2412
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
19.1
95
295
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
19.1
524
3693
A02BC05
ATC
esomeprazole; systemic
1.8
18.8
483
3321
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
18.8
18
*
L03
ICPC
Low back symptom/complaint
2.0
18.8
315
1868
J01MA02
ATC
ciprofloxacin; systemic
1.8
18.7
447
3003
X58
ICD-10 Finland
Exposure to other specified factors
2.4
18.7
174
796
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
24.2
18.7
26
11
L76
ICPC
Fracture: other
4.6
18.6
65
147
E21.2
ICD-10 Finland
Other hyperparathyroidism
193.1
18.6
19
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
18.6
194
941
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
18.4
126
485
NF3AA
NOMESCO Finland
Femur X-ray examination
6.4
18.2
48
78
ZXA10
NOMESCO Finland
Bilateral
2.0
18.1
256
1419
S97
ICPC
Chronic ulcer skin
3.3
17.8
93
299
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
+∞
17.8
17
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
5.1
17.6
56
115
SPAT1216
SPAT
Assessment of functional ability
2.1
17.5
218
1145
L17
ICPC
Foot/toe symptom/complaint
1.9
17.4
313
1896
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
17.4
396
2603
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.3
17.3
65
158
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
17.1
464
3217
UJF32
NOMESCO Finland
Coloscopy
1.9
17.1
321
1972
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
7.5
17.1
40
55
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.6
17.0
59
133
XG410
NOMESCO Finland
Flow-volume spirometry
3.7
17.0
76
217
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.4
16.9
62
148
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
6.6
16.9
43
67
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
16.8
204
1057
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.7
16.8
57
125
M01CB01
ATC
sodium aurothiomalate; parenteral
5.7
16.8
48
87
B01AB05
ATC
enoxaparin; parenteral
1.8
16.7
381
2496
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.8
16.7
73
204
H26.3
ICD-10 Finland
Drug-induced cataract
11.8
16.6
30
26
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.5
16.5
80
243
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.0
16.5
98
343
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
16.4
107
399
A06AD11
ATC
lactulose; oral
2.2
16.4
191
972
E0000UV
ATC
NA
1.7
16.3
467
3281
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.8
16.2
106
397
N02BE01
ATC
paracetamol; systemic, rectal
2.0
16.1
973
8571
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
16.1
113
441
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
16.0
110
426
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
60.9
15.8
18
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
15.7
231
1289
M05BA01
ATC
etidronic acid; systemic
9.9
15.7
31
32
A07EC01
ATC
sulfasalazine; oral, rectal
2.6
15.7
121
501
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.6
15.7
54
121
SPAT1263
SPAT
Sampling
1.7
15.7
494
3558
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
15.7
15
*
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
+∞
15.7
15
*
A07AA02
ATC
nystatin; oral
2.7
15.5
107
416
S52.0
ICD-10 Finland
Fracture of upper end of ulna
6.4
15.4
40
64
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
15.3
84
281
J01DB01
ATC
cefalexin; oral
1.8
15.3
904
7790
R13
ICD-10 Finland
Dysphagia
2.9
15.3
96
350
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
15.2
317
2005
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
15.1
144
663
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
15.0
151
717
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
15.3
14.9
24
16
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
15.3
14.9
24
16
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
14.9
106
418
L04AB01
ATC
etanercept; parenteral
7.3
14.8
35
49
Z94.0
ICD-10 Finland
Kidney transplant status
10.6
14.8
28
27
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.5
14.7
120
510
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
14.7
132
593
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.7
14.7
102
398
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.1
14.6
80
267
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
14.6
109
443
BBA50
NOMESCO Finland
Total parathyroidectomy
+∞
14.6
14
*
BBA20
NOMESCO Finland
Exploration of parathyroid gland
+∞
14.6
14
*
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
8.2
14.6
32
40
R53
ICD-10 Finland
Malaise and fatigue
1.9
14.5
251
1488
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
14.5
104
413
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
3.8
14.5
61
166
W19
ICD-10 Finland
Unspecified fall
2.5
14.4
120
518
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.7
14.4
49
109
5BA08
NOMESCO Finland
NA
13.6
14.2
24
18
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.9
14.1
39
68
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
14.1
257
1548
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.1
14.1
44
89
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
14.0
108
446
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.3
14.0
42
81
A46
ICD-10 Finland
Erysipelas
2.1
14.0
168
863
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.6
14.0
64
187
SPAT1301
SPAT
No procedures
1.7
13.9
377
2575
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.7
13.9
61
172
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
13.8
67
205
R03BB04
ATC
tiotropium bromide; inhalant
2.4
13.6
125
567
E31.00
ICD-10 Finland
APECED syndrome
+∞
13.6
13
*
C03DA01
ATC
spironolactone; oral
2.2
13.5
141
681
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
13.5
102
418
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
13.4
46
103
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
26.1
13.4
18
7
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.7
13.2
385
2674
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
13.1
194
1084
SPAT1255
SPAT
Intravenous administration of medicine
2.7
13.1
93
368
3025
Kela drug reimbursment
Calcium carbonate
28.7
13.0
17
6
K07.60
ICD-10 Finland
Snapping jaw
3.3
12.9
66
210
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
12.9
314
2068
NDG74
NOMESCO Finland
Fusion of first IP joint
22.8
12.9
18
8
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
12.9
67
216
M54
ICD-10 Finland
Dorsalgia
2.2
12.9
136
657
S18
ICPC
Laceration/cut
1.6
12.8
471
3472
ZZH31
NOMESCO Finland
Bone allograft, small pieces
7.3
12.8
30
42
R06.0
ICD-10 Finland
Dyspnoea
1.7
12.8
303
1979
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
9.2
12.8
26
29
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
12.7
61
185
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
12.7
453
3312
J01MA14
ATC
moxifloxacin; systemic
2.4
12.7
113
503
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
70.7
12.6
14
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.8
12.6
81
300
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
32.4
12.6
16
5
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.8
12.6
52
140
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.2
12.6
134
650
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
12.5
12
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.2
12.5
47
116
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
20.3
12.5
18
9
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
131.4
12.5
13
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.6
12.4
93
379
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.5
12.4
43
98
J46
ICD-10 Finland
Status asthmaticus
3.9
12.4
50
132
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.3
12.3
37
72
S82.0
ICD-10 Finland
Fracture of patella
5.3
12.3
37
72
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.3
398
2828
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
12.3
103
445
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.7
12.3
54
153
N06AX21
ATC
duloxetine; oral
2.2
12.3
133
653
S72.3
ICD-10 Finland
Fracture of shaft of femur
7.5
12.2
28
38
M48.0
ICD-10 Finland
Spinal stenosis
2.0
12.2
159
840
C07AB07
ATC
bisoprolol; oral
1.6
12.2
520
3969
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.2
12.1
64
209
R11
ICD-10 Finland
Nausea and vomiting
2.4
12.1
105
463
E87.6
ICD-10 Finland
Hypokalaemia
3.5
12.0
55
161
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
12.0
119
560
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
12.0
401
2874
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
12.0
62
200
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
12.0
60
189
M81.5
ICD-10 Finland
Idiopathic osteoporosis
6.9
12.0
29
43
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
11.9
513
3914
A02BA02
ATC
ranitidine; systemic
1.8
11.9
242
1502
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
11.9
78
294
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.4
11.9
58
179
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
11.9
136
681
A12BA01
ATC
potassium chloride; oral
2.9
11.8
73
265
NH1AD
NOMESCO Finland
Ankle and foot CT
5.0
11.8
37
76
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.0
11.8
37
76
H03BB01
ATC
carbimazole; oral
3.0
11.8
67
230
L02
ICPC
Back symptom/complaint
2.3
11.7
113
525
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.7
11.6
39
86
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
11.5
67
234
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
11.5
158
855
R03AC02
ATC
salbutamol; inhalant
1.5
11.4
569
4480
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.1
11.4
43
107
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
11.4
78
301
ZX114
NOMESCO Finland
Intramuscular
5.4
11.2
33
63
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
11.2
396
2865
SPAT1310
SPAT
Counselling related to known health issue
1.6
11.2
363
2571
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
11.2
199
1178
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.7
11.2
74
281
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
11.1
246
1564
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
20.3
11.1
16
8
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
11.1
194
1145
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
11.1
70
259
WX110
NOMESCO Finland
Local anesthesy
1.6
11.1
716
5975
A01AB09
ATC
miconazole; local oral
2.1
11.0
129
654
H02AA02
ATC
fludrocortisone; oral
9.3
11.0
22
24
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.9
11.0
66
236
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.0
11.0
64
224
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
11.0
89
379
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
3.8
11.0
45
121
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.4
10.9
51
153
B01AA03
ATC
warfarin; systemic
1.8
10.8
214
1313
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
10.8
73
281
WX204
NOMESCO Finland
Axillary plexus blockaced
3.4
10.8
51
154
L04AB04
ATC
adalimumab; parenteral
4.8
10.8
35
75
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.2
10.8
56
182
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
10.8
113
545
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
10.7
126
637
L84
ICD-10 Finland
Corns and callosities
3.5
10.7
49
144
327
Kela drug reimbursment
strontium ranelate
28.3
10.7
14
5
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
6.8
10.7
26
39
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
10.7
115
561
N06AA09
ATC
amitriptyline; systemic
2.1
10.6
131
677
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.1
10.5
40
101
E21.4
ICD-10 Finland
Other specified disorders of parathyroid gland
+∞
10.4
10
*
E23.03
ICD-10 Finland
Lack of ACTH
+∞
10.4
10
*
25298
ICD-8 Finland
Diseases of parathyroid gland, Alii definiti
+∞
10.4
10
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
10.4
218
1361
ZXA00
NOMESCO Finland
Right side
1.6
10.4
320
2228
N18.8
ICD-10 Finland
Other chronic renal failure
4.0
10.4
40
102
T71
ICPC
Malignant neoplasm thyroid
16.2
10.4
16
10
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
10.3
149
820
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
10.3
99
460
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
4.8
10.3
33
70
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
10.7
10.3
19
18
G47.3
ICD-10 Finland
Sleep apnoea
1.8
10.3
198
1202
S72.2
ICD-10 Finland
Subtrochanteric fracture
9.7
10.3
20
21
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
10.2
53
172
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
10.1
134
714
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
4.1
10.1
38
95
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
10.1
154
863
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
10.1
522
4104
N05CF01
ATC
zopiclone; oral
1.6
10.1
364
2631
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.1
10.1
123
632
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
7.3
10.0
23
32
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.3
10.0
92
419
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.5
10.0
34
77
J01DA01
ATC
[U] cefalexin; systemic
1.5
9.9
664
5510
H26.4
ICD-10 Finland
After-cataract
2.0
9.9
127
668
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.1
9.9
54
182
NAU20
NOMESCO Finland
Removal of internal fixation device from spine or neck
12.3
9.9
17
14
JN4BD
NOMESCO Finland
Extensive body CT
2.0
9.8
130
692
N05CD07
ATC
temazepam; oral
1.9
9.8
152
856
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
9.8
150
843
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
9.8
179
1068
R03DA04
ATC
theophylline; systemic, rectal
2.7
9.8
66
255
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.5
9.7
73
299
XF640
NOMESCO Finland
NA
3.2
9.7
49
156
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
9.7
172
1015
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
6.2
9.7
25
41
L75
ICPC
Fracture: femur
5.6
9.7
27
49
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
4.5
9.7
33
75
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.4
9.7
45
135
E22.1
ICD-10 Finland
Hyperprolactinaemia
55.5
9.7
11
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.7
202
1257
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.9
9.6
30
62
WW200
NOMESCO Finland
Immunization
3.6
9.6
42
120
J01FA06
ATC
roxithromycin; oral
1.5
9.6
434
3299
P01AB01
ATC
metronidazole; oral, rectal
1.5
9.6
435
3306
R52.2
ICD-10 Finland
Other chronic pain
3.2
9.6
49
158
K02.1
ICD-10 Finland
Caries of dentine
1.5
9.6
550
4403
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
5.5
9.5
27
50
R60.0
ICD-10 Finland
Localized oedema
1.9
9.5
137
752
X57
ICD-10 Finland
Unspecified privation
4.2
9.5
35
86
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
9.5
59
215
SXC03
NOMESCO Finland
Other oral or dental procedure
6.7
9.5
23
35
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.6
9.4
21
28
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
6.3
9.4
24
39
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
+∞
9.4
9
*
2522
FHL
Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)
+∞
9.4
9
*
78892
ICD-8 Finland
Other general symptoms, Hypocalcaemia
+∞
9.4
9
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.0
9.4
36
92
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
9.3
47
150
XG466
NOMESCO Finland
Sleep oxymetry
3.6
9.3
41
118
SPAT1325
SPAT
Vaccination
1.5
9.3
401
3007
NFJ62
NOMESCO Finland
Internal fixation of fracture of other parts of femur with plate
8.8
9.3
19
22
WX002
NOMESCO Finland
Sedation and analgesia
1.7
9.3
236
1551
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
3.7
9.2
38
104
N05BA01
ATC
diazepam; systemic, rectal
1.9
9.1
150
862
TK800
NOMESCO Finland
Hemodialysis
4.6
9.1
30
66
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.0
9.1
112
577
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
11.6
9.1
16
14
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
9.1
181
1109
WZC30
NOMESCO Finland
Teaching
1.9
9.1
146
835
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
15.7
9.0
14
9
M01AH02
ATC
rofecoxib; oral
1.8
9.0
164
977
S22.3
ICD-10 Finland
Fracture of rib
2.4
8.9
73
311
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
7.5
8.9
20
27
D68.9
ICD-10 Finland
Coagulation defect, unspecified
18.8
8.9
13
7
J04AB02
ATC
rifampicin; systemic
5.8
8.9
24
42
M96.6
ICD-10 Finland
Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate
12.6
8.9
15
12
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
8.0
8.9
19
24
A02BC01
ATC
omeprazole; systemic
1.6
8.9
308
2194
R4180
NOMESCO Finland
Podiatric therapy
6.9
8.9
21
31
L14
ICPC
Leg/thigh symptom/complaint
2.2
8.9
89
423
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
8.8
233
1549
A01
ICPC
Pain general/multiple sites
2.1
8.8
100
501
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
4.2
8.8
32
78
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.7
8.8
37
103
G72.9
ICD-10 Finland
Myopathy, unspecified
9.6
8.8
17
18
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.0
8.8
34
88
R03AK08
ATC
formoterol and beclometasone; inhalant
2.9
8.8
52
186
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
5.7
8.8
24
43
NA3BA
NOMESCO Finland
Lumbar spine extensive X-ray examination without contrast
14.2
8.7
14
10
A04
ICPC
Weakness/tiredness general
1.8
8.7
158
940
M54.6
ICD-10 Finland
Pain in thoracic spine
2.3
8.6
80
366
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.0
8.6
49
168
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.3
8.6
25
48
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.4
8.6
72
313
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.5
8.6
38
110
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
5.5
8.6
24
44
SPAT1153
SPAT
Removal of sutures
1.5
8.6
353
2611
SPAT1210
SPAT
Application of cast or individual aid
2.5
8.6
63
257
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.1
8.5
17
19
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
10.1
8.5
16
16
T99
ICPC
Endocr/metab/nutrit disease other
4.6
8.5
28
62
D07AB08
ATC
desonide; topical
1.9
8.5
120
656
NCJ64
NOMESCO Finland
Other internal fixation of fracture of forearm
5.4
8.5
24
45
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
8.5
146
852
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
8.4
119
648
M79.6
ICD-10 Finland
Pain in limb
1.5
8.4
390
2959
M40.1
ICD-10 Finland
Other secondary kyphosis
90.7
8.4
9
*
NAK40
NOMESCO Finland
Vertebroplasty
90.7
8.4
9
*
H05BX01
ATC
cinacalcet; oral
90.7
8.4
9
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.5
8.4
62
253
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
7.9
8.4
18
23
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.9
8.4
49
174
J01DA06
ATC
[U] cefuroxime; systemic
1.8
8.4
162
982
K50.9
ICD-10 Finland
Crohn disease, unspecified
5.1
8.4
25
50
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.2
8.3
30
73
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
8.3
550
4484
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
8.3
331
2430
WX202
NOMESCO Finland
Supraclavicular plexus blockade
4.8
8.3
26
55
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
8.3
92
458
J45.8
ICD-10 Finland
Mixed asthma
3.0
8.3
47
162
ZZA00
NOMESCO Finland
Split skin graft
3.1
8.2
43
142
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
4.0
8.2
31
79
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.4
8.2
69
302
B03XA01
ATC
erythropoietin; parenteral
7.6
8.2
18
24
NDG30
NOMESCO Finland
Fusion of wrist, total
7.6
8.2
18
24
NDG76
NOMESCO Finland
Fusion of DIP joint
6.1
8.2
21
35
SPAT1234
SPAT
Support of social functional capacity
2.4
8.2
68
293
WX725
NOMESCO Finland
Noninvasive ventilation
2.6
8.2
57
226
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
8.1
635
5333
RS221
NOMESCO Finland
NA
4.7
8.1
26
56
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
8.2
8.1
17
21
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
8.1
83
396
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.9
8.1
19
28
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
8.1
120
666
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.4
8.1
37
111
Z31.5
ICD-10 Finland
Genetic counselling
2.6
8.1
56
221
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
22.2
8.0
11
5
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
5.9
8.0
21
36
J01FA01
ATC
erythromycin; systemic
1.8
8.0
142
837
L13
ICPC
Hip symptom/complaint
1.7
7.9
194
1261
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.6
7.9
55
217
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
3.4
7.9
37
113
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.4
7.9
65
282
Z71.8
ICD-10 Finland
Other specified counselling
1.6
7.9
243
1673
R03AC12
ATC
salmeterol; inhalant
2.6
7.9
55
218
N03AX09
ATC
lamotrigine; oral
2.8
7.9
48
176
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
7.9
236
1617
H25.8
ICD-10 Finland
Other senile cataract
1.8
7.9
136
795
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
7.9
40
130
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.9
279
1991
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.5
7.9
61
256
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
4.7
7.8
25
54
SPAT1260
SPAT
Consultation of another employee
1.6
7.8
200
1313
NB1AD
NOMESCO Finland
Shoulder CT examination
3.7
7.8
32
88
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.9
7.8
30
78
J01AA02
ATC
doxycycline; systemic
1.5
7.7
832
7406
NAG42
NOMESCO Finland
Posterior fusion of cervical spine with or without fixation
15.1
7.7
12
8
NDC40
NOMESCO Finland
Secondary prosthetic replacement in of joint of finger or metacarpal
15.1
7.7
12
8
9284
FHL
Wrist ossification surgery
15.1
7.7
12
8
RD210
NOMESCO Finland
NA
3.9
7.7
30
79
N03AE01
ATC
clonazepam; systemic
2.3
7.7
69
313
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
4.8
7.7
24
51
-50
ICPC
Medication/prescr/renewal
2.6
7.6
54
216
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
18.5
7.6
11
6
9289
FHL
Other measure in this category
18.5
7.6
11
6
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
11.9
7.6
13
11
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
8.9
7.6
15
17
M13.9
ICD-10 Finland
Arthritis, unspecified
2.2
7.5
79
381
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.1
7.5
39
129
A02BC03
ATC
lansoprazole; oral
1.5
7.5
308
2264
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.2
7.5
37
118
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.2
7.4
37
119
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.3
7.4
69
317
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
7.4
147
897
ZX108
NOMESCO Finland
Inhalation
7.7
7.4
16
21
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.4
175
1124
L01BB01
ATC
NA
13.5
7.4
12
9
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.5
7.4
12
9
C08CA02
ATC
felodipine; oral
1.9
7.4
107
589
R06AE07
ATC
cetirizine; oral
1.4
7.4
461
3688
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
7.4
197
1308
JN4AD
NOMESCO Finland
Body CT examination
2.1
7.4
81
402
J02AC01
ATC
fluconazole; systemic
1.4
7.4
446
3544
R03AC03
ATC
terbutaline; inhalant
1.7
7.4
158
990
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
7.3
91
473
7330A
ICD-9 Finland
Other disorders of bone and cartilage, Osteoporosis[OSTEOPOROSIS CENTRALIS]
+∞
7.3
7
*
E27.2
ICD-10 Finland
Addisonian crisis
+∞
7.3
7
*
M81.1
ICD-10 Finland
Postoophorectomy osteoporosis
+∞
7.3
7
*
25200
ICD-8 Finland
Diseases of parathyroid gland, Hyperparathyroidism
+∞
7.3
7
*
H01AC01
ATC
somatropin; parenteral
+∞
7.3
7
*
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
+∞
7.3
7
*
K59.1
ICD-10 Finland
Functional diarrhoea
2.3
7.3
66
300
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
7.3
89
461
NHQ40
NOMESCO Finland
Amputation of toe
4.5
7.3
24
54
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.2
7.3
75
359
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
6.3
7.3
18
29
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
7.2
178
1154
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.2
272
1961
L99
ICPC
Musculoskeletal disease other
3.3
7.2
34
105
K07
ICPC
Swollen ankles/oedema
2.3
7.2
63
282
UJF92
NOMESCO Finland
Capsular endoscopy
3.6
7.2
30
84
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.0
7.2
27
69
S82.1
ICD-10 Finland
Fracture of upper end of tibia
3.9
7.2
28
74
ZZH30
NOMESCO Finland
Bone allograft
30.2
7.2
9
*
E83.59
ICD-10 Finland
Other disorders of calcium metabolism
20.2
7.1
10
5
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
20.2
7.1
10
5
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.6
7.1
50
199
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
5.1
7.1
21
42
NG1AD
NOMESCO Finland
Knee CT examination
4.1
7.1
26
65
N18.0
ICD-10 Finland
End-stage renal disease
6.1
7.1
18
30
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.9
7.1
41
145
S72.4
ICD-10 Finland
Fracture of lower end of femur
5.7
7.1
19
34
C08CA05
ATC
nifedipine; systemic
2.1
7.1
74
359
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
8.8
7.1
14
16
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
7.1
258
1845
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.2
7.1
67
312
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.3
7.0
59
259
H02AB08
ATC
triamcinolone; systemic
7.0
7.0
16
23
Z01.9
ICD-10 Finland
Special examination, unspecified
2.2
7.0
71
340
A07AA09
ATC
vancomycin; oral
4.5
7.0
23
52
R4120
NOMESCO Finland
Occupational therapy
2.1
7.0
76
377
D68.8
ICD-10 Finland
Other specified coagulation defects
6.4
6.9
17
27
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
6.9
111
634
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.1
6.9
36
120
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
7.6
6.9
15
20
M33.2
ICD-10 Finland
Polymyositis
13.9
6.9
11
8
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.4
6.9
31
93
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.5
6.9
49
198
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.5
6.9
49
198
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
6.8
46
180
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
6.8
388
3035
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.5
6.8
30
88
M01AE02
ATC
naproxen; oral, rectal
1.4
6.8
573
4810
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
6.8
87
456
G03XC01
ATC
raloxifene; oral
11.0
6.8
12
11
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
6.8
83
430
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
6.8
296
2200
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
5.3
6.8
19
36
K22.2
ICD-10 Finland
Oesophageal obstruction
5.7
6.8
18
32
A01AB10
ATC
natamycin; local oral
2.7
6.8
44
168
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
40.3
6.8
8
*
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
40.3
6.8
8
*
2754A
ICD-9 Finland
Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]
40.3
6.8
8
*
N04BC06
ATC
cabergoline; oral (dopamine agonists)
16.8
6.7
10
6
RS222
NOMESCO Finland
NA
4.3
6.7
23
54
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.1
6.7
34
111
N02AC04
ATC
dextropropoxyphene; oral
2.5
6.7
51
213
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.1
6.7
24
59
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.6
6.7
45
176
NA2AD
NOMESCO Finland
Thoracic spine CT examination
7.2
6.7
15
21
TAB00
NOMESCO Finland
Lumbar puncture
2.6
6.7
47
187
ZZH40
NOMESCO Finland
Substitute of bone
4.9
6.7
20
41
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
4.9
6.7
20
41
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.9
6.7
20
41
N19
ICD-10 Finland
Unspecified kidney failure
2.9
6.7
38
132
Z01.2
ICD-10 Finland
Dental examination
1.4
6.7
404
3198
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
6.6
181
1207
WX882
NOMESCO Finland
High dependency care
2.7
6.6
43
164
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
5.5
6.6
18
33
M02AA10
ATC
ketoprofen; topical
1.6
6.6
175
1160
E000001
ATC
NA
1.5
6.6
206
1422
J01CA04
ATC
amoxicillin; systemic
1.4
6.6
841
7582
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
8.8
6.6
13
15
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.4
6.5
53
229
S76
ICPC
Skin infection other
2.2
6.5
63
294
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
10.1
6.5
12
12
M41.9
ICD-10 Finland
Scoliosis, unspecified
4.2
6.5
23
56
J01FA10
ATC
azithromycin; systemic
1.4
6.5
584
4943
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
5.1
6.5
19
38
NC2AA
NOMESCO Finland
Forearm X-ray examination
4.0
6.5
24
61
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
6.2
6.5
16
26
T84.1
ICD-10 Finland
Mechanical complication of internal fixation device of bones of limb
5.7
6.5
17
30
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
6.4
60
277
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.1
6.4
69
338
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.9
6.4
24
62
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
6.4
69
340
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.9
6.4
37
132
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
6.4
221
1560
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
6.6
6.3
15
23
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
6.6
6.3
15
23
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
5.2
6.3
18
35
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
11.1
6.3
11
10
Z94.4
ICD-10 Finland
Liver transplant status
11.1
6.3
11
10
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.3
6.3
29
89
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
9.3
6.3
12
13
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.8
6.3
102
586
347
Kela drug reimbursment
denosumab
18.1
6.3
9
5
9527
FHL
Alloarthroplasty, implant or endoprosthesis
18.1
6.3
9
5
SPAT1172
SPAT
Guidance concerning hydration
3.1
6.3
32
106
N06AX11
ATC
mirtazapine; oral
1.4
6.3
326
2501
A12AA03
ATC
calcium gluconate; systemic
+∞
6.3
6
*
BBA99
NOMESCO Finland
Other operations on parathyroid gland
+∞
6.3
6
*
E31.0
ICD-10 Finland
Autoimmune polyglandular failure
+∞
6.3
6
*
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
6.3
6
*
25810
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Polyglandular dysfunction
+∞
6.3
6
*
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
+∞
6.3
6
*
2581B
ICD-9 Finland
Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]
+∞
6.3
6
*
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.8
6.2
38
141
J96.1
ICD-10 Finland
Chronic respiratory failure
3.5
6.2
27
79
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
26.8
6.2
8
*
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
26.8
6.2
8
*
137
Kela drug reimbursment
Uraemia requiring dialysis
7.1
6.2
14
20
P01BA01
ATC
chloroquine; systemic
7.1
6.2
14
20
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.9
6.2
34
118
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.5
6.2
47
194
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.7
6.2
117
705
EBA00
NOMESCO Finland
Extraction of tooth
1.4
6.2
312
2376
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.0
6.2
32
107
E000002
ATC
NA
1.7
6.2
118
711
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.7
6.2
40
152
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.4
6.2
48
204
TGC00
NOMESCO Finland
Bronchial lavation
3.0
6.2
33
113
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
6.2
44
178
NC1BA
NOMESCO Finland
Elbow extensive X-ray examination
5.8
6.2
16
28
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
7.7
6.1
13
17
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
6.1
106
624
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.9
6.1
23
60
NDG79
NOMESCO Finland
Other excision, reconstruction or fusion of joint of II-V finger
12.6
6.1
10
8
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.1
6.1
31
103
9531
FHL
Arthrodesis of the hand joint
8.6
6.1
12
14
S32.5
ICD-10 Finland
Fracture of pubis
4.4
6.1
20
46
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
6.1
381
3023
L60.0
ICD-10 Finland
Ingrowing nail
2.5
6.1
46
191
UJD02
NOMESCO Finland
Gastroscopy
2.2
6.1
58
273
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
6.0
208
1464
S72.1
ICD-10 Finland
Pertrochanteric fracture
3.0
6.0
32
109
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
10.1
6.0
11
11
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.9
6.0
35
125
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
2.7
6.0
39
148
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
6.0
89
496
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.3
6.0
28
87
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
4.0
6.0
22
56
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
624
1308
8.36
317.85
7.0
4.6
mmol/l
1.2
1.1
11.42
583
1202
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
528
827
10.17
307.65
5.0
3.0
ng/l
57.2
78.8
5.56
426
703
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
136
58
26.12
192.35
6.7
6.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1026
4787
6.76
191.76
5.2
2.2
nmol/l
85.0
79.3
9.41
955
4221
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1095
5618
7.57
176.95
19.6
5.8
mmol/l
1.2
1.2
29.81
897
4717
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
90
15
64.46
162.71
2.1
1.5
ug/l
0.3
0.2
—
69
9
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1020
5140
5.85
161.64
16.7
5.2
mmol/l
1.2
1.2
30.59
959
4603
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
141
96
16.38
161.09
6.0
4.6
u/ml
88.7
53.9
0.21
39
32
(3018418) pH of Serum or Plasma
763
3379
4.11
135.37
13.2
3.5
ph
7.4
7.4
0.40
229
611
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
157
172
10.26
132.53
3.1
2.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
502
1712
4.18
128.41
5.3
3.1
mmol/l
0.8
0.8
4.36
470
1589
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
289
665
5.32
121.75
5.0
3.2
pmol/l
4.3
4.5
2.18
261
578
(3036481) Cortisol [Moles/volume] in Serum or Plasma
342
960
4.50
112.17
2.5
1.9
nmol/l
317.8
381.8
3.21
317
871
(3015377) Calcium [Moles/volume] in Serum or Plasma
793
3971
3.62
109.12
4.7
3.3
mmol/l
2.3
2.4
38.11
691
3421
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
56
12
48.76
95.86
2.3
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
280
907
3.67
72.53
2.3
2.9
g/l
65.3
66.5
1.86
242
817
(3004588) Protein electrophoresis panel - Serum or Plasma
253
771
3.84
71.67
2.2
2.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
270
916
3.47
64.57
11.9
3.3
mmol/l
1.2
1.2
15.44
261
776
(3024561) Albumin [Mass/volume] in Serum or Plasma
789
4878
2.61
59.28
7.3
4.2
g/l
34.2
35.4
6.87
747
4518
(3006315) Basophils [#/volume] in Blood
841
5367
2.65
59.04
11.1
5.6
e9/l
0.0
0.0
0.69
776
4582
(3001604) Monocytes [#/volume] in Blood
837
5348
2.63
58.28
11.1
5.6
e9/l
0.6
0.6
3.08
773
4556
(3013115) Eosinophils [#/volume] in Blood
856
5556
2.63
57.22
11.6
5.9
e9/l
0.2
0.2
0.03
786
4822
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
145
346
4.60
56.60
2.4
3.6
ratio
1.0
1.7
0.79
11
28
(3034860) Kappa light chains.free [Mass/volume] in Serum
147
356
4.54
56.31
2.6
3.6
mg/l
33.7
61.2
0.94
102
301
(3019198) Lymphocytes [#/volume] in Blood
844
5489
2.58
55.36
11.2
5.6
e9/l
1.7
1.9
2.62
788
4781
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
146
358
4.47
55.02
2.6
3.7
mg/l
26.1
60.7
1.31
102
303
(42870588) Differential panel, method unspecified - Blood
635
3672
2.45
53.17
10.5
5.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1117
8499
3.47
51.89
14.6
7.1
u/l
78.0
78.9
0.18
1081
7938
(3022096) Basophils/100 leukocytes in Blood
767
4877
2.43
51.18
11.6
5.8
%
0.7
0.7
0.36
718
4506
(3006504) Eosinophils/100 leukocytes in Blood
780
5015
2.42
50.48
11.5
5.8
%
2.7
2.8
0.13
730
4631
(3019069) Monocytes/100 leukocytes in Blood
781
5036
2.41
50.03
12.3
6.0
%
8.6
8.6
0.03
732
4672
(3005719) IgG [Mass/volume] in Serum or Plasma
217
759
3.24
48.49
4.5
2.8
g/l
9.6
10.5
1.98
202
689
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
516
2807
2.40
48.40
3.1
2.2
mg/l
3.7
3.1
3.74
443
2374
(3002030) Lymphocytes/100 leukocytes in Blood
788
5157
2.37
47.95
11.9
5.9
%
25.0
27.8
10.72
739
4755
(40760888) Immunoglobulin light chains.free panel - Serum
115
260
4.76
47.81
2.8
4.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
907
6342
2.48
47.03
14.1
8.9
e9/l
4.6
4.1
7.16
831
5507
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
67
91
7.71
46.98
1.4
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
774
5088
2.32
45.71
11.1
5.7
%
60.3
57.4
9.27
726
4712
(3036603) Volume of Urine
54
60
9.35
44.49
2.0
1.5
ml
1918.7
2078.6
—
13
8
(3028026) IgM [Mass/volume] in Serum or Plasma
182
612
3.30
43.15
2.7
1.7
g/l
1.1
1.4
1.30
163
550
(3019309) Folate [Moles/volume] in Red Blood Cells
424
2206
2.38
43.02
1.9
1.7
nmol/l
1242.8
1191.8
0.42
329
1611
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
315
1433
2.59
42.79
3.5
2.3
%
18.9
21.8
3.37
270
1220
(3032080) INR in Blood by Coagulation assay
691
4412
2.23
42.70
12.3
8.8
inr
1.2
1.2
0.01
225
1204
(3022948) Iron [Moles/volume] in Serum or Plasma
351
1689
2.49
42.27
3.5
2.2
umol/l
10.8
12.6
5.52
325
1556
(3020779) Urea [Moles/volume] in Serum or Plasma
218
851
2.88
39.73
10.4
6.0
mmol/l
10.5
9.3
1.07
210
808
(3004789) Transferrin [Mass/volume] in Serum or Plasma
323
1538
2.47
39.47
3.4
2.2
g/l
2.3
2.3
0.63
301
1421
(3023368) Bacteria identified in Blood by Culture
500
2884
2.20
38.84
6.5
4.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
876
6314
2.23
37.97
7.1
4.3
mmol/l
6.6
6.7
1.54
847
5913
(3019225) pH of Specimen
259
1132
2.61
37.76
12.5
3.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
266
1180
2.58
37.60
4.8
4.2
u/l
249.3
253.3
0.16
239
1103
(3027945) Reticulocytes/100 erythrocytes in Blood
275
1244
2.54
37.29
3.0
2.6
%
1.9
1.8
0.06
244
1096
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
437
2432
2.21
36.71
1.4
1.3
u/ml
0.9
1.7
1.97
130
618
(3007164) IgA [Mass/volume] in Serum or Plasma
391
2084
2.26
36.49
2.1
1.5
g/l
2.3
2.3
0.25
254
1194
(3007853) Bacteria identified in Skin by Aerobe culture
263
1182
2.54
36.05
2.7
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
91
217
4.44
35.27
4.6
3.9
mmol/l
3.2
2.9
0.37
73
152
(3009445) Proteinase 3 Ab [Units/volume] in Serum
136
434
3.39
34.84
2.0
1.5
u/ml
15.5
11.7
—
9
5
(3042936) Bacteria identified in Isolate by Culture
306
1502
2.36
34.41
3.4
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1078
8639
2.57
34.08
8.5
4.2
pmol/l
16.5
14.9
48.74
991
7783
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
144
484
3.23
33.89
2.5
1.7
g/l
1.5
1.5
0.04
123
418
(3044927) Protein electrophoresis panel - Urine
65
121
5.61
33.61
1.2
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
218
926
2.63
33.39
3.5
2.6
e9/l
71.7
71.1
0.09
172
704
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
195
784
2.75
33.29
2.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
166
621
2.92
32.40
5.4
3.8
mmol/l
2.7
1.9
1.58
139
464
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
172
657
2.87
32.30
5.6
3.8
kpa
5.4
5.2
1.45
162
613
(3010421) pH of Blood
99
269
3.90
32.20
4.9
3.6
ph
7.4
7.4
0.28
90
214
(3002179) Metamyelocytes/100 leukocytes in Blood
196
804
2.70
32.12
5.0
3.7
%
0.8
0.6
0.74
65
167
(1616796) Gas panel - Central venous blood
86
213
4.26
31.71
4.0
3.3
—
—
—
0
0
(3009343) pH of Capillary blood
169
648
2.85
31.49
5.6
3.8
ph
7.4
7.4
1.75
25
81
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
537
3381
2.01
31.38
2.4
2.1
u/l
143.9
211.2
1.74
499
3163
(3017181) Myelocytes/100 leukocytes in Blood
207
884
2.60
31.24
5.0
3.8
%
1.0
1.0
0.03
76
238
(3021440) Promyelocytes/100 leukocytes in Blood
198
844
2.59
29.92
5.1
3.9
%
0.1
0.2
0.31
74
216
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
110
338
3.47
29.81
1.8
1.6
titre
656.0
118.8
—
5
17
(3025159) Blasts/100 leukocytes in Blood
189
789
2.64
29.80
5.2
4.0
%
0.1
0.5
0.47
66
180
(3013707) Erythrocyte sedimentation rate by Westergren method
1022
8169
2.25
29.63
8.8
4.2
mm/h
16.4
13.2
8.10
952
7513
(3035637) Corticotropin [Mass/volume] in Plasma
56
104
5.59
29.02
1.7
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
392
2260
2.06
28.77
7.7
4.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
789
5785
1.95
28.46
8.3
5.8
umol/l
10.6
11.1
0.37
750
5466
(3009214) Lutropin [Units/volume] in Serum or Plasma
71
165
4.50
28.39
1.5
1.3
u/l
12.8
11.8
0.19
60
125
(3001122) Ferritin [Mass/volume] in Serum or Plasma
667
4633
1.92
28.27
4.2
2.7
ug/l
127.1
111.5
0.46
602
4228
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
334
1824
2.12
28.26
2.3
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
395
2301
2.04
28.06
3.6
2.5
e6/l
5.3
7.0
2.01
355
2012
(3026782) Osmolality of Urine
376
2159
2.05
27.74
4.2
2.7
mosm/kgh2o
484.0
531.8
4.50
327
1830
(3011412) CD3 cells [#/volume] in Blood
53
98
5.60
27.59
1.6
1.9
e9/l
1.1
1.1
0.12
40
55
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
386
2247
2.03
27.36
4.6
2.8
mmol/l
2.4
2.5
8.77
336
1975
(3037121) Protein [Mass/volume] in Urine
111
370
3.19
26.35
2.4
3.1
g/l
0.4
0.3
0.28
35
132
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
124
444
2.99
26.03
1.6
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
124
444
2.99
26.03
1.6
2.3
g/l
7.5
7.6
0.11
92
345
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
123
443
2.97
25.54
1.6
2.3
g/l
3.6
3.8
0.62
90
330
(3037522) Nuclear Ab [Titer] in Serum
270
1410
2.16
25.34
1.6
1.3
titre
532.2
570.8
0.13
69
319
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
417
3.02
25.34
1.6
2.4
g/l
3.0
3.2
1.02
90
338
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
117
421
2.96
24.31
1.6
2.4
g/l
9.4
10.2
1.17
94
362
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
76
209
3.80
24.26
4.5
3.3
%
62.6
58.2
2.10
76
209
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
43
75
5.90
23.78
1.6
1.9
%
17.9
10.4
3.08
26
40
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
87
266
3.44
23.71
4.0
4.5
mg/l
1.8
1.5
1.39
80
242
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
42
72
6.00
23.64
1.7
1.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
142
4.38
23.44
2.3
1.7
g/l
0.6
0.9
0.63
41
109
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
109
386
2.99
23.29
2.1
2.6
g/l
0.4
1.0
1.33
86
336
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
212
1040
2.24
23.08
3.1
2.0
g/l
0.2
0.2
0.85
199
975
(3024139) IgG subclass 3 [Mass/volume] in Serum
46
88
5.38
23.08
2.5
1.3
g/l
0.4
0.4
0.00
34
62
(3027135) IgG subclass 1 [Mass/volume] in Serum
46
88
5.38
23.08
2.5
1.3
g/l
6.5
7.4
0.63
34
62
(3028192) IgG subclass 2 [Mass/volume] in Serum
46
88
5.38
23.08
2.5
1.3
g/l
2.5
2.7
0.21
34
62
(3003181) Sodium [Moles/volume] in Urine
75
214
3.66
22.69
1.6
1.3
mmol/l
60.1
59.7
0.02
60
173
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
698
5132
1.79
22.68
5.6
3.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
125
485
2.75
22.56
5.7
3.8
—
—
—
0
0
(4062490)
46
90
5.26
22.52
2.5
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
519
3506
1.81
22.38
3.5
2.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
72
202
3.72
22.33
4.4
3.1
e9/l
4.5
4.2
0.51
72
202
(3037756) Immunofixation for Serum or Plasma
82
253
3.39
22.03
1.7
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
657
4774
1.77
21.96
19.4
9.4
e9/l
0.0
0.0
0.65
588
3872
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
95
322
3.11
21.89
2.7
1.6
g/l
0.2
0.2
0.04
87
307
(3027801) Oxygen [Partial pressure] in Arterial blood
231
1198
2.13
21.80
7.3
6.4
kpa
11.8
12.2
0.59
220
1143
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
231
1198
2.13
21.80
7.3
6.4
kpa
5.1
5.1
0.22
221
1143
(3016502) Oxygen saturation in Arterial blood
211
1056
2.20
21.80
7.6
6.7
%
95.2
95.8
0.67
201
1015
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
220
1122
2.16
21.66
5.0
3.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
487
3262
1.80
21.36
4.8
3.2
e6/l
19.7
74.8
1.97
416
2484
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
112
424
2.80
21.17
1.9
2.0
u/l
39.8
39.9
0.01
93
370
(3009508) Creatinine [Moles/volume] in Urine
503
3409
1.78
21.15
3.7
3.0
mmol/l
6.4
6.7
0.97
446
2832
(3003396) Base excess in Arterial blood by calculation
229
1198
2.11
21.07
7.4
6.4
mmol/l
1.8
1.2
1.00
191
943
(40767503) Oxygen content in Capillary blood by calculation
71
208
3.56
20.65
3.4
2.3
%
15.5
15.8
0.19
33
105
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
110
418
2.78
20.63
2.3
2.0
ug/l
2.9
1.9
0.40
93
364
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
84
274
3.21
20.63
2.2
2.2
mg/l
11.5
12.3
0.29
72
253
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
501
3422
1.76
20.29
3.7
2.3
u/l
63.4
57.8
0.40
463
3122
(3000991) Gas panel - Venous blood
181
877
2.24
20.17
10.6
6.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
100
366
2.88
20.11
1.7
2.3
g/l
37.3
37.7
0.24
81
318
(3030467) Casts [#/volume] in Urine by Automated count
453
3020
1.77
19.86
4.6
3.1
e6/l
0.3
0.5
1.30
384
2262
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
496
3394
1.75
19.85
4.1
3.1
ng/l
1300.6
1257.3
0.12
426
2873
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
589
4230
1.73
19.82
5.1
3.7
ng/l
35.8
41.8
0.28
475
2970
(3031040) Bacteria [#/volume] in Urine by Automated count
915
7435
1.81
19.74
7.1
4.9
e6/l
3375.3
2810.0
0.12
12
105
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
94
336
2.94
19.73
2.6
1.6
g/l
1.2
1.2
0.27
87
320
(3013512) EKG study
478
3246
1.75
19.59
5.0
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
932
7623
1.82
19.58
7.9
4.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
108
418
2.73
19.55
6.0
4.3
mmol/l
25.5
24.9
1.04
100
392
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
84
283
3.11
19.55
2.7
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
442
2951
1.76
19.12
4.5
3.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
150
692
2.32
18.72
4.5
4.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
63
182
3.59
18.72
1.3
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
94
347
2.84
18.60
1.5
2.3
g/l
0.0
0.0
0.49
83
319
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
638
4742
1.69
18.46
2.5
2.0
pmol/l
96.6
95.7
0.15
324
2277
(3026008) Bacteria identified in Urine by Culture
545
3894
1.70
18.23
4.4
3.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
52
134
4.00
18.18
2.8
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1147
10138
2.26
18.11
9.8
5.1
mu/l
3.0
1.9
0.51
1070
9198
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
57
162
3.64
17.36
6.9
4.8
iu/ml
972.6
357.5
0.56
12
23
(3018095) Leukocytes [#/volume] in Urine
538
3871
1.67
17.25
5.6
3.7
e6/l
84.3
106.7
0.39
436
2686
(3014576) Chloride [Moles/volume] in Serum or Plasma
232
1307
1.95
17.12
9.2
5.8
mmol/l
102.7
104.1
3.19
222
1273
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
45
109
4.24
17.09
1.3
1.2
u/l
69.5
56.3
0.39
35
79
(3002032) Base excess in Venous blood by calculation
188
984
2.07
17.06
6.5
3.6
mmol/l
2.6
2.0
1.35
168
796
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
402
2690
1.72
16.82
3.5
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
404
2709
1.72
16.77
1.8
1.5
nmol/l
23.3
21.4
0.39
338
2261
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
48
124
3.98
16.73
1.9
1.5
%
63.5
61.7
0.11
32
85
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
84
311
2.82
16.53
1.8
1.6
iu/ml
0.1
0.1
0.02
22
60
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
227
1285
1.93
16.47
2.0
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
98
395
2.60
16.36
1.4
1.2
u/ml
0.3
1.1
—
5
30
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
87
331
2.75
16.27
1.5
2.4
g/l
0.0
0.0
0.00
76
305
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
86
331
2.71
15.73
1.4
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
43
108
4.09
15.58
1.5
1.2
mosm/kgh2o
272.6
276.0
0.36
36
76
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
118
539
2.31
15.01
8.7
7.8
mmol/l
24.9
24.4
0.67
109
502
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
84
328
2.67
14.94
1.4
2.4
g/l
0.0
0.0
0.00
75
304
(3002173) Hemoglobin [Mass/volume] in Arterial blood
182
986
1.99
14.92
8.3
6.7
g/l
117.5
119.4
0.59
174
950
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
74
271
2.84
14.87
1.6
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
169
893
2.03
14.86
5.3
4.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
35
78
4.59
14.76
1.6
1.8
%
44.0
45.4
—
5
9
(40768797) Stomach Pathology biopsy report
257
1568
1.80
14.58
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
221
1288
1.87
14.54
2.1
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
128
3.69
14.47
1.5
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
59
193
3.16
14.45
2.0
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
26
7.80
14.45
3.1
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
62
212
3.02
14.09
1.7
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
44
121
3.73
14.08
1.5
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
168
3.25
13.68
1.6
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
48
144
3.42
13.51
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
65
236
2.85
13.28
1.7
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
66
242
2.82
13.25
1.7
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
73
4.47
13.13
1.6
1.9
e6/l
414.0
753.3
2.06
11
29
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
178
3.12
13.07
1.7
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
69
262
2.73
12.97
4.8
2.8
mmol/l
26.5
25.4
0.97
63
228
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
30
67
4.56
12.64
1.3
1.2
u/l
24.0
14.8
0.88
25
58
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
109
518
2.21
12.60
7.3
3.8
mmol/l
24.8
24.2
0.84
99
467
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
42
121
3.55
12.58
15.7
6.3
mg/l
13.3
12.0
0.65
36
112
(3035350) Ketones [Presence] in Urine by Test strip
675
5387
1.54
12.56
5.5
3.9
estimate
0.0
0.0
0.00
192
985
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
75
302
2.58
12.56
1.9
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
381
2682
1.60
12.38
3.1
2.6
umol/l
4277.5
6502.4
0.43
321
2288
(3021901) Oxygen saturation in Capillary blood
54
185
3.00
12.25
3.8
2.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
388
2749
1.59
12.25
5.5
3.7
%
90.9
91.2
0.05
379
2673
(3019550) Sodium [Moles/volume] in Serum or Plasma
1203
11140
2.33
12.12
33.9
16.5
mmol/l
139.2
139.6
4.11
1185
10852
(3009261) Glucose [Presence] in Urine by Test strip
682
5484
1.52
12.05
5.6
4.0
estimate
0.0
0.0
0.80
186
965
(3023103) Potassium [Moles/volume] in Serum or Plasma
1203
11165
2.29
11.62
34.1
16.6
mmol/l
3.9
4.0
6.63
1184
10855
(3017143) Hepatitis C virus Ab [Presence] in Serum
172
998
1.84
11.34
1.7
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1165
10701
1.99
11.31
31.6
14.2
mg/l
22.1
23.0
0.44
1051
8449
(3000494) Fungus identified in Specimen by Culture
205
1259
1.75
11.16
2.2
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
11
11.00
11.07
5.1
3.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
321
2.42
11.06
9.2
3.1
u/ml
0.4
0.4
0.13
53
191
(3025941) Bacteria identified in Stool by Culture
114
580
2.06
11.06
1.5
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
671
5436
1.49
11.04
7.3
5.4
estimate
0.0
0.0
0.50
187
990
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
76
328
2.40
11.01
3.0
2.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
47
159
3.03
10.92
3.1
3.2
%
0.9
1.4
0.92
40
121
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
81
361
2.33
10.91
2.5
1.9
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
19
32
6.01
10.88
1.6
2.0
e6/l
242.1
318.0
0.31
14
15
(36660697) Celiac disease serology panel - Serum
152
866
1.86
10.60
1.2
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
70
297
2.44
10.53
1.7
1.8
iu/l
6.6
4.9
0.62
29
99
(3017446) Testosterone [Moles/volume] in Serum or Plasma
81
367
2.29
10.51
3.1
2.0
nmol/l
12.5
12.8
0.11
70
318
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
341
2417
1.56
10.48
2.8
1.7
mg/l
1.5
1.3
0.33
268
1850
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
38
116
3.35
10.45
1.5
1.2
pmol/l
286.3
262.5
0.16
31
89
(3041096) Erythrocytes [Presence] in Urine by Automated
385
2820
1.52
10.13
5.0
3.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
341
2434
1.55
10.10
1.8
1.7
pmol/l
463.8
16278334.2
1.57
284
1972
(3000475) Leukocytes [#/volume] in Synovial fluid
64
266
2.48
10.07
2.2
1.7
e6/l
18341.9
12544.4
0.37
47
199
(3020891) Body temperature
89
429
2.15
9.95
5.6
4.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
393
2902
1.51
9.91
6.5
4.4
estimate
0.0
0.0
0.80
186
969
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
90
438
2.13
9.82
2.5
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
206
1312
1.68
9.75
3.1
2.1
ug/g
173.3
116.6
1.74
155
1027
(3026389) Candida sp identified in Specimen by Organism specific culture
43
148
2.97
9.72
2.2
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
26
6.22
9.47
1.3
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
57
231
2.54
9.47
2.9
2.1
g/l
120.5
126.6
0.90
46
171
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
198
1261
1.67
9.36
1.7
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
6
21.87
9.36
1.2
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
66
4.00
9.35
1.8
1.6
u/l
5.0
7.3
0.29
20
34
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
20
41
4.94
9.33
1.4
1.6
nmol/l
3.6
1.6
0.57
15
34
(3022145) Colonoscopy Study observation
195
1240
1.68
9.26
1.5
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
781
6643
1.45
9.25
4.5
3.0
u/l
56.5
46.7
1.54
708
6106
(3022217) INR in Platelet poor plasma by Coagulation assay
216
1412
1.64
9.22
31.2
25.3
inr
1.3
1.3
0.01
31
180
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
83
402
2.14
9.18
2.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1105
10113
1.68
9.16
27.2
13.4
ml/min/173m2
76.7
78.0
1.03
994
8253
(3042631) Mycobacterium sp identified in Specimen
40
137
2.98
9.14
2.1
2.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
119
658
1.89
9.10
6.9
6.7
mmol/l
25.8
24.5
2.51
108
612
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
102
541
1.96
8.82
9.6
8.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
559
4498
1.43
8.80
2.3
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
67
303
2.28
8.77
1.4
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
32
5.37
8.69
1.3
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
516
4099
1.43
8.68
6.1
4.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
124
706
1.84
8.65
4.8
2.9
e9/l
4.9
4.0
1.52
75
545
(3008757) Leukocyte morphology finding [Identifier] in Blood
36
120
3.06
8.63
3.4
3.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
379
2846
1.47
8.58
10.4
6.6
—
—
—
0
0
(3017704) Immunofixation for Urine
25
66
3.84
8.54
1.6
1.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
21
49
4.34
8.42
2.6
2.7
u/ml
980.1
1342.4
0.44
21
49
(3000570) Elastase.pancreatic [Mass/mass] in Stool
71
335
2.19
8.40
1.8
1.4
ug/g
258.2
297.4
1.06
42
196
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
118
3.02
8.24
1.3
1.2
nmol/l
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
436
3387
1.44
8.17
4.3
3.0
u/l
33.3
32.2
0.14
407
3215
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
135
2.87
8.16
1.8
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
263
1850
1.53
8.13
3.6
2.7
e6/l
1.2
1.4
0.54
168
1012
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
64
3.80
8.09
2.3
2.6
%
45.3
40.7
0.45
12
22
(3023183) Ammonium ion [Moles/volume] in Plasma
49
201
2.50
7.98
2.6
3.1
umol/l
33.9
36.2
0.24
43
167
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
63
290
2.23
7.93
1.3
1.2
u/ml
5.4
3.0
—
10
34
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
37
132
2.86
7.90
1.3
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
27
80
3.43
7.82
2.3
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
267
1899
1.51
7.81
1.4
1.3
iu/ml
49.6
36.2
0.57
89
618
(3005322) IgE [Units/volume] in Serum or Plasma
111
632
1.83
7.75
1.5
1.2
u/ml
131.5
155.5
0.24
98
570
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
63
295
2.19
7.61
1.3
1.2
u/ml
5.0
10.8
0.70
14
57
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
15
7.39
7.56
1.5
1.1
ng/l
69.7
82.7
0.34
11
15
(3048879) Bone marrow aspiration report
14
25
5.65
7.55
1.2
2.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
114
663
1.79
7.43
1.8
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
43
172
2.55
7.39
1.3
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
53
234
2.32
7.37
1.3
1.2
u/ml
21.7
6.3
—
6
18
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
31
105
3.00
7.26
1.9
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
64
310
2.12
7.12
1.4
1.2
u/ml
31.8
25.3
—
5
18
(40761511) CBC panel - Blood by Automated count
1177
11091
1.76
7.08
28.9
13.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
61
3.65
7.04
3.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
110
646
1.77
6.94
1.5
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
47
203
2.37
6.88
1.7
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
135
847
1.66
6.71
3.4
2.6
ml/min/173m2
65.8
64.7
0.11
76
355
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
251
1818
1.47
6.62
1.4
1.3
u/ml
32.8
12.2
2.04
92
680
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
80
3.17
6.46
1.4
1.1
titre
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
21
60
3.54
6.45
3.4
2.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
28
96
2.96
6.45
1.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
96
2.96
6.45
1.5
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
96
2.96
6.45
1.5
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
96
2.96
6.45
1.5
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
33
124
2.71
6.44
4.2
3.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
18
6.16
6.43
1.3
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
172
2.43
6.41
1.4
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
78
422
1.90
6.41
5.1
5.0
%
1.6
1.6
0.03
69
395
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
86
3.07
6.37
2.2
1.3
%
26.9
32.6
0.33
18
57
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
15
6.71
6.32
5.1
2.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
98
2.90
6.23
3.1
2.8
%
62.2
57.7
0.43
21
61
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
67
3.32
6.15
1.6
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
65
337
1.98
6.06
3.9
3.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
40
171
2.38
6.02
2.0
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
26
89
2.96
6.02
2.4
2.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
68
3.27
6.02
1.6
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
31
4.56
5.99
1.4
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
37
153
2.46
5.99
1.3
1.3
u/ml
112.8
114.1
—
8
32
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
147
2.49
5.98
2.3
2.5
mg/l
38.9
29.8
—
10
39
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
29
106
2.78
5.98
2.6
2.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
16
6.29
5.96
1.3
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
49
3.71
5.93
1.7
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
80
3.04
5.82
1.3
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
50
3.64
5.77
1.7
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
28
4.68
5.74
1.3
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
37
4.09
5.63
3.0
4.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1194
11392
1.72
5.57
19.4
10.5
u/l
23.2
24.3
1.66
1157
10956
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
16
42
3.85
5.54
2.9
2.5
ug/l
17.6
—
—
5
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
21
67
3.17
5.48
1.3
1.4
u/l
4.5
7.1
1.39
16
56
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
5
16.09
5.41
1.3
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
74
417
1.82
5.40
5.2
5.1
%
0.9
0.9
0.22
65
390
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
172
1208
1.49
5.25
3.3
2.5
umol/l
11.3
7.6
0.59
143
1034
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
75
2.97
5.16
2.0
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
28
109
2.60
5.15
1.6
1.4
nmol/l
0.4
0.4
0.02
23
88
(40761535) Cells panel - Urine sediment
134
900
1.55
5.04
5.6
3.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
280
2164
1.38
5.04
4.6
3.9
ng/l
439.8
266.6
0.27
235
1719
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
229
1712
1.41
5.02
4.3
2.8
e6/l
2.9
3.2
0.15
138
884
(3012516) Albumin [Mass/volume] in Urine
397
3238
1.33
5.01
3.5
3.2
mg/l
560.8
289.9
0.42
245
1920
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
108
692
1.61
4.97
1.8
1.7
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
17
51
3.36
4.89
1.2
1.1
u/l
175.7
23.4
0.74
11
38
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
17
51
3.36
4.89
1.2
1.1
u/l
258.3
75.1
0.88
12
40
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
38
175
2.21
4.88
1.3
1.2
u/l
20.9
21.4
0.04
32
151
(3020961) Endomysium IgA Ab [Titer] in Serum
85
515
1.70
4.86
1.1
1.2
—
187.9
—
0
14
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
48
243
2.01
4.84
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
27
108
2.53
4.73
1.9
2.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
23
85
2.74
4.69
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
34
152
2.27
4.69
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
30
127
2.39
4.67
1.2
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
74
2.87
4.67
1.1
1.2
u/ml
0.7
2.1
0.48
12
35
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
58
3.13
4.65
1.7
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
193
1420
1.42
4.61
11.9
6.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
413
3421
1.31
4.60
4.4
3.8
mg/mmol
10.1
7.6
0.47
254
2006
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
23
86
2.71
4.60
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
23
86
2.71
4.60
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
23
86
2.71
4.60
1.1
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
29
122
2.41
4.58
2.4
1.5
nmol/l
41.9
42.7
0.06
29
116
(40763480) Human metapneumovirus Ag [Presence] in Specimen
7
5
14.07
4.58
1.4
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
25
98
2.58
4.57
1.3
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
11
25
4.43
4.56
1.7
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1060
9946
1.38
4.54
7.1
5.9
mmol/mol
40.5
39.9
1.02
960
9110
(3014148) Varicella zoster virus Ab [Titer] in Serum
24
93
2.61
4.49
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
32
143
2.27
4.43
1.6
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
137
953
1.49
4.39
2.5
2.4
ug/l
7.4
6.0
0.30
109
815
(44790049)
27
113
2.42
4.33
1.6
1.5
—
—
—
0
0
(44790047)
27
113
2.42
4.33
1.6
1.5
—
—
—
0
0
(44790048)
27
113
2.42
4.33
1.6
1.5
—
—
—
0
0
(44806118)
27
113
2.42
4.33
1.6
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
107
2.46
4.32
1.5
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
43
219
2.00
4.30
1.3
1.2
u/ml
45.1
41.6
—
9
27
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
138
966
1.48
4.29
4.6
2.8
ng/l
172.6
203.1
0.73
128
878
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
56
3.06
4.25
1.6
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
56
3.06
4.25
1.6
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
56
3.06
4.25
1.6
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
56
3.06
4.25
1.6
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
16
51
3.16
4.21
1.4
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
56
314
1.82
4.21
3.3
2.5
%
92.8
91.8
0.10
51
295
(46235355) HIV 1 and 2 tests - Meaningful Use set
195
1461
1.39
4.20
1.9
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
121
2.34
4.19
1.5
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
13
6.96
4.16
1.3
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
13
6.96
4.16
1.3
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
13
6.96
4.16
1.3
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
85
2.62
4.15
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
85
2.62
4.15
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
104
2.43
4.07
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
43
225
1.94
4.00
3.3
3.4
u/ml
92.6
1644.4
0.78
38
212
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
240
1.91
3.96
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
240
1.91
3.96
1.3
1.3
—
—
—
0
0
(4035726)
139
993
1.45
3.90
1.5
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
24
4.19
3.89
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
79
500
1.62
3.87
1.3
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
9
15
6.03
3.82
5.7
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
15
49
3.09
3.81
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
37
187
2.01
3.81
1.3
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
34
3.55
3.77
1.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
66
2.75
3.76
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
66
2.75
3.76
1.4
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
19
72
2.66
3.74
1.4
1.2
titre
418.6
96.4
—
7
11
(3019977) pH of Arterial blood
15
50
3.02
3.69
1.9
3.6
ph
7.4
7.4
—
7
16
(3036489) Thrombin time
64
389
1.68
3.68
3.0
2.1
s
22.0
21.1
0.33
55
347
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
30
3.69
3.64
1.5
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
56
331
1.72
3.57
5.0
3.6
mmol/l
3.8
3.8
0.09
51
306
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
21
86
2.47
3.56
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
46
3.07
3.53
1.9
3.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
54
317
1.73
3.53
6.6
6.4
mmol/l
1.2
1.3
0.30
47
280
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
743
0.56
3.45
1.7
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
175
1334
1.36
3.39
1.3
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
53
2.85
3.36
1.3
1.2
ratio
1.1
1.1
—
5
22
(3023323) Follitropin [Units/volume] in Serum or Plasma
60
369
1.66
3.33
1.4
1.3
iu/l
27.4
30.5
0.27
49
313
(3003338) MCHC [Mass/volume]
826
8871
0.81
3.31
38.0
19.1
g/l
329.2
331.2
7.35
819
8793
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
149
2.04
3.27
1.4
1.3
u/ml
325.8
265.0
0.45
19
81
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
24
109
2.22
3.26
1.8
1.3
u/l
37.8
31.2
0.32
19
89
(3024928) Oxygen saturation in Venous blood
40
220
1.84
3.26
9.0
3.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
250
1.79
3.23
1.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
21
91
2.33
3.18
1.0
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
104
2.23
3.17
1.3
1.3
e6/l
399600.3
177789.5
0.35
15
73
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
158
1.99
3.16
1.4
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
42
712
0.58
3.16
1.3
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
49
290
1.72
3.14
3.6
2.7
%
219.5
186.4
1.16
42
279
(3024471) HLA-A [Type]
9
20
4.52
3.11
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
20
4.52
3.11
1.0
1.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
16
62
2.60
3.05
1.2
1.2
u/l
13.6
10.5
0.48
16
54
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
181
1410
1.33
3.05
5.1
4.6
%
34.8
33.5
0.76
126
898
(3018572) Chloride [Moles/volume] in Blood
41
233
1.78
3.03
7.0
6.9
mmol/l
103.9
105.3
1.20
34
208
(3039000) Anion gap in Blood
41
233
1.78
3.03
7.0
6.9
mmol/l
10.8
11.1
0.20
34
208
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
45
2.91
3.03
1.6
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
45
2.91
3.03
1.6
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
12
5.86
3.02
2.1
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
29
147
2.00
3.01
1.8
1.2
u/ml
7.2
4.0
0.44
12
58
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
686
6236
1.22
3.01
3.2
2.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
21
4.31
2.99
1.1
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
72
476
1.54
2.99
6.6
3.4
%
51.0
48.5
0.38
72
467
(3004775) Volume in Urine collected for unspecified duration
18
75
2.42
2.97
3.1
2.2
ml
694.2
580.9
0.54
13
49
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
46
2.84
2.92
1.6
1.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
21
95
2.23
2.90
1.3
1.1
u/ml
49.2
33.5
—
5
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
95
2.23
2.90
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
127
945
1.38
2.88
2.0
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
15
58
2.61
2.88
3.1
2.1
min
479.3
492.5
—
10
42
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
29
150
1.95
2.86
1.8
1.2
u/ml
2.3
3.8
0.39
11
44
(3028433) Virus identified in Specimen by Culture
12
41
2.95
2.86
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
53
330
1.63
2.84
1.9
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
26
130
2.02
2.82
1.8
2.0
u/ml
4.2
2048.6
0.51
26
125
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
53
2.66
2.80
2.0
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
23
3.93
2.77
1.0
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
1214
11828
1.51
2.75
44.3
21.3
fl
91.3
91.2
0.52
1204
11648
(3035941) MCH [Entitic mass]
1214
11829
1.51
2.74
44.2
21.2
pg
30.1
30.3
2.82
1204
11648
(3026361) Erythrocytes [#/volume] in Blood
1214
11830
1.51
2.73
44.5
21.3
e12/l
4.3
4.4
12.13
1199
11481
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
48
2.73
2.72
1.4
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
48
2.73
2.72
1.4
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1214
11831
1.51
2.71
44.6
21.4
e9/l
7.2
6.7
11.47
1199
11475
(3000963) Hemoglobin [Mass/volume] in Blood
1214
11833
1.50
2.69
44.9
21.5
g/l
128.4
132.6
19.49
1204
11653
(42529406) Shigella sp [Presence] in Stool by Culture
55
351
1.59
2.69
1.4
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
42
250
1.70
2.68
1.7
2.1
u/l
10329.0
2162.4
—
8
109
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
19
4.23
2.68
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
16
67
2.41
2.63
1.2
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
54
345
1.59
2.63
1.4
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1213
11826
1.49
2.63
44.5
21.3
e9/l
265.4
254.6
5.52
1199
11510
(3045716) Anion gap in Serum or Plasma
13
49
2.67
2.62
2.2
2.1
mmol/l
10.0
9.8
—
7
40
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
120
2.02
2.62
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
939
8867
1.22
2.57
34.1
17.7
%
14.2
13.7
14.83
928
8669
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
11
5.47
2.54
1.0
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
820
7648
1.20
2.53
4.6
3.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
349
1.57
2.52
1.4
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
32
180
1.80
2.49
1.8
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
144
1.89
2.47
1.7
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
145
1.88
2.43
1.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
145
1.88
2.43
1.7
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
34
2.96
2.41
2.7
1.2
ug/l
11.2
9.1
—
10
34
(3024869) Neuronal Ab [Presence] in Serum
6
12
5.02
2.40
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
22
3.65
2.36
4.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
35
2.87
2.30
1.7
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
18
3.90
2.25
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
142
1.85
2.24
1.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
142
1.85
2.24
1.7
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
48
2.51
2.19
1.1
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
234
1.64
2.19
3.8
2.3
ug/min
103.0
75.4
0.19
21
138
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
250
1.62
2.17
1.5
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
144
1.82
2.15
1.7
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
28
160
1.77
2.11
1.2
1.1
iu/ml
71.6
130.0
—
6
38
(40768793) Breast Pathology biopsy report
19
356
0.53
2.10
1.3
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
43
2.57
2.10
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
43
2.57
2.10
1.1
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
31
2.92
2.07
1.4
1.9
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
10
5.01
2.07
1.0
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
131
1036
1.29
2.02
2.9
2.2
u/l
32.6
35.5
0.31
120
875
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
44
2.51
2.01
2.7
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
21
3.35
1.96
2.9
2.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
16
3.76
1.93
1.5
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
72
2.10
1.86
1.9
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
35
2.58
1.80
1.0
1.1
miu/ml
2213.0
1656.5
—
9
35
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
15
74
2.04
1.75
1.0
1.0
mg/l
321.7
289.5
1.08
15
62
(4015189)
7
24
2.93
1.72
3.6
3.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
61
2.14
1.72
1.6
2.9
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
13
3.86
1.71
2.4
1.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
13
3.86
1.71
4.4
5.4
—
—
—
0
0
(44806071)
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
15
75
2.01
1.70
1.1
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
90
1.90
1.65
1.9
2.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
25
2.81
1.65
2.3
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
14
3.58
1.61
2.2
2.0
umol/l
11.5
19.3
—
5
14
(40757494) Bilirubin.total [Moles/volume] in Blood
12
56
2.15
1.61
1.8
2.8
—
29.3
—
0
5
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
144
1188
1.24
1.61
3.2
4.0
ug/l
56.6
21.8
0.29
123
963
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
63
2.07
1.60
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
24
144
1.68
1.58
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
12
57
2.12
1.55
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
41
282
1.47
1.53
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
147
1.64
1.48
1.1
1.1
—
—
—
0
0
(4010399)
97
773
1.28
1.47
1.6
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
28
2.51
1.45
1.3
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
125
1.69
1.44
1.1
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
35
504
0.69
1.41
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
177
0.51
1.40
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
177
0.51
1.40
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
178
0.50
1.40
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
178
0.50
1.40
1.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
33
480
0.68
1.40
1.7
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
40
2.26
1.40
1.1
1.1
iu/ml
343.2
202.0
—
9
40
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
46
2.18
1.40
1.1
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
88
698
1.28
1.39
1.7
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
142
1.63
1.39
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
60
2.01
1.38
1.2
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
23
2.62
1.37
1.2
1.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
20
120
1.68
1.34
2.6
2.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
92
739
1.26
1.33
1.2
1.2
iu/ml
159.7
149.9
0.07
33
281
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
146
0.48
1.32
1.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
24
2.51
1.30
1.7
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
137
1.62
1.30
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
69
1.89
1.28
2.6
1.5
g/l
0.8
1.0
2.61
13
69
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
800
0.76
1.28
1.3
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
62
1.94
1.28
3.3
1.8
ug/l
22.2
9.8
0.43
12
52
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
100
1.71
1.23
1.1
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
8
37
2.17
1.21
1.3
1.1
%
114.3
111.8
—
8
32
(3005033) Fetal Nuchal fold Thickness US
7
145
0.48
1.20
1.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
287
0.62
1.20
2.2
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
325
2950
1.14
1.20
1.6
1.7
mmol/l
1.3
1.4
0.47
272
2470
(3045788) Cell count panel - Pleural fluid
16
94
1.71
1.17
1.5
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
20
2.51
1.15
1.0
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
2.3
—
2.6
—
0
18
(3032773) Endomysium IgG Ab [Titer] in Serum
15
88
1.71
1.11
1.3
1.1
—
—
—
0
0
(4027681)
10
51
1.97
1.11
1.5
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
78
634
1.25
1.06
2.6
2.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
138
1.53
1.03
1.1
1.1
u/ml
0.2
5.3
—
8
74
(3050129) First trimester maternal screen panel - Serum or Plasma
12
202
0.59
1.02
1.2
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
47
1.92
1.02
1.0
11.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
21
310
0.67
1.02
1.0
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
23
156
1.48
0.99
1.2
1.1
u/ml
7.8
1.9
—
8
64
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
23
2.18
0.98
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
365
0.71
0.97
1.5
1.7
mg/l
5.0
3.9
0.19
20
266
(1002224) Polysomnography panel
26
365
0.71
0.97
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
54
1.86
0.96
2.2
1.1
—
—
—
0
0
(44813793)
12
69
1.75
0.96
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1075
10516
1.14
0.96
5.3
4.7
mmol/l
5.8
5.9
2.28
959
9446
(3009466) Valproate [Moles/volume] in Serum or Plasma
22
149
1.48
0.95
8.3
4.8
umol/l
344.4
358.7
0.12
16
132
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
13
77
1.70
0.95
1.2
1.4
—
51.4
—
0
7
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
52
1.74
0.92
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
289
2650
1.12
0.91
6.0
3.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
143
1.48
0.90
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
71
1.70
0.89
7.8
3.1
—
—
—
0
0
(4281824)
9
152
0.59
0.89
1.1
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
42
1.91
0.88
1.6
1.8
ug/l
17.6
224.1
—
8
34
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
61
746
0.81
0.87
2.6
3.6
u/ml
40.0
65.3
0.47
55
721
(3009542) Hematocrit [Volume Fraction] of Blood
986
9618
1.11
0.84
29.3
15.8
%
37.9
38.9
2.80
573
6589
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
31
1.94
0.84
1.8
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
31
1.94
0.84
1.8
2.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
50
399
1.26
0.83
1.4
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
190
0.63
0.83
1.1
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
258
1.33
0.82
1.3
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
13
81
1.61
0.81
1.1
1.4
—
371.1
—
0
9
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1028
10056
1.11
0.81
4.4
4.0
mmol/l
1.3
1.3
0.25
909
9037
(3044290) Cell count panel - Cerebral spinal fluid
28
207
1.36
0.80
1.2
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
149
0.60
0.79
1.0
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
98
1.54
0.78
1.3
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
90
1.56
0.78
1.4
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
82
1.59
0.78
2.4
2.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
125
0.56
0.77
1.3
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
34
1.77
0.76
3.2
1.8
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
28
0.00
0.76
0.0
1.3
—
0.9
—
0
21
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
53
1.70
0.75
1.1
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
54
1.67
0.74
2.0
3.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
219
1.33
0.73
2.0
1.7
nmol/l
0.8
0.8
0.05
21
181
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
55
1.64
0.73
1.0
1.4
—
—
—
0
0
(4268621)
15
100
1.51
0.73
2.8
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
171
1543
1.12
0.73
4.7
4.9
ug/l
2.7
2.5
0.19
146
1363
(3024263) Appearance of Synovial fluid
9
56
1.61
0.72
1.6
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
84
1.55
0.72
1.2
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
111
974
1.15
0.72
1.9
1.7
%
1.5
1.4
0.43
90
842
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
151
1.40
0.71
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
50
608
0.82
0.71
4.8
3.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
101
1.49
0.70
1.1
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
7
41
1.71
0.70
1.3
1.1
g/l
0.3
0.3
—
7
31
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
42
1.67
0.68
1.0
1.2
%
—
83.5
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
120
0.58
0.67
1.3
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
267
1.28
0.67
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
43
1.63
0.67
1.4
1.3
nmol/l
125.9
144.3
—
7
43
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
188
1.34
0.66
1.6
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
28
1.79
0.66
1.2
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
145
1.39
0.66
1.8
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
29
1.73
0.64
1.8
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
18
129
1.40
0.63
6.2
2.9
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
234
1.29
0.63
1.3
1.4
e6/l
11.5
17.8
0.24
24
178
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
11
71
1.55
0.62
1.0
1.0
ng/l
187.2
335.4
—
5
42
(3047189) Immunofixation for 24 hour Urine
8
49
1.64
0.62
3.3
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
30
1.67
0.61
1.8
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
130
1.39
0.61
1.2
1.1
u/ml
0.3
1.5
—
5
60
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
11
72
1.53
0.59
1.0
1.0
ng/l
25.0
51.8
—
5
41
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
11
72
1.53
0.59
1.0
1.0
ng/l
705.8
632.0
—
5
42
(44806420)
6
35
1.72
0.57
2.3
2.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
87
0.57
0.56
1.8
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
17
124
1.38
0.56
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
90
0.55
0.55
1.2
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
63
543
1.17
0.55
1.4
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
142
1.34
0.54
1.2
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
61
1.48
0.53
1.3
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
61
1.48
0.53
1.3
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
147
0.68
0.53
1.1
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
98
1093
0.89
0.52
1.4
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
185
1715
1.09
0.51
1.5
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
65
1.39
0.50
1.4
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
43
363
1.19
0.48
2.1
2.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
256
2411
1.08
0.48
6.8
4.3
kg/l
1.0
1.0
0.06
36
364
(3003694) ABO and Rh group [Type] in Blood
296
2810
1.07
0.45
1.5
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
103
1.36
0.45
1.1
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
139
1.30
0.43
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
130
0.69
0.43
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
3.2
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
8
57
1.41
0.42
1.3
4.5
—
51.4
—
0
10
(3013139) Helicobacter pylori Ag [Presence] in Stool
68
762
0.89
0.41
1.2
1.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
199.1
—
0
7
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.6
—
0
10
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
15
0.00
0.41
0.0
3.0
—
0.8
—
0
15
(4198724)
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
71
1.41
0.39
1.6
1.8
—
—
—
0
0
(4306422)
17
133
1.28
0.38
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1056
10436
1.07
0.38
5.0
4.5
mmol/l
1.6
1.5
1.47
945
9463
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
74
818
0.90
0.37
2.4
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
343
0.84
0.37
1.5
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
47
412
1.15
0.37
2.2
2.9
u/ml
476.5
574.8
0.08
39
355
(4034850)
41
357
1.15
0.35
15.7
9.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
135
1.26
0.35
1.8
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
45
1.33
0.33
1.3
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
46
1.31
0.33
1.3
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
189
1992
0.94
0.32
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
229
1.18
0.32
1.6
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
258
1.17
0.31
3.2
3.2
nmol/l
0.9
0.8
0.53
20
201
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
184
1.20
0.30
1.8
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
93
1.29
0.30
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
141
0.78
0.29
1.5
1.3
—
—
—
0
0
(4024509)
14
112
1.25
0.28
1.5
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
63
1.27
0.27
1.1
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
63
1.27
0.27
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
36
403
0.89
0.25
1.6
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
28
245
1.15
0.25
1.6
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
246
1.14
0.23
1.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
247
1.14
0.22
1.6
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
144
1.18
0.22
3.3
2.4
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
11
0.00
0.21
0.0
1.2
—
0.0
—
0
6
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
1.2
—
0
5
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
11.9
—
0
10
(1761482) Bacteria [#/volume] in Urine by Culture
33
296
1.12
0.21
5.5
4.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
89
1.24
0.21
1.3
1.1
u/ml
13.7
4.1
—
5
32
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
13
0.00
0.21
0.0
1.4
—
12.0
—
0
6
(3001729) Color of Synovial fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
(4146454)
14
118
1.19
0.19
3.6
2.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
22
249
0.88
0.19
5.1
3.9
mg/l
26.2
26.4
0.01
11
147
(3011288) Drugs identified in Urine by Screen method
18
156
1.16
0.18
2.4
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
332
3396
0.97
0.17
3.2
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1059
10524
1.04
0.17
5.0
4.5
mmol/l
4.7
4.7
1.00
950
9614
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1082
10760
1.04
0.16
5.4
5.1
mmol/l
2.6
2.7
3.59
971
9775
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
151
0.86
0.15
1.1
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
102
1.18
0.15
1.2
1.0
u/ml
3.4
2.8
—
7
34
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
102
1.18
0.15
1.0
1.1
%
88.8
96.2
0.42
12
96
(3011648) Oxygen content in Venous blood
9
80
1.13
0.15
2.2
4.2
%
10.5
10.9
—
9
80
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
334
1.08
0.14
1.9
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
96
0.83
0.13
14.1
2.2
%
13.9
13.2
—
8
96
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
99
0.81
0.13
1.0
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
94
1.17
0.13
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
117
0.85
0.13
1.4
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
54
513
1.05
0.11
2.0
2.0
—
—
—
0
0
(4094501)
27
288
0.94
0.09
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
62
0.81
0.08
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
55
571
0.96
0.08
1.1
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
71
726
0.98
0.04
2.3
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
125
1234
1.01
0.03
4.2
4.3
%
21.9
21.3
0.17
62
573
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
88
893
0.98
0.03
3.0
3.0
ug/l
0.8
0.7
0.06
65
565
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
261
1.04
0.02
1.4
1.3
miu/ml
153.5
239.2
—
10
113
(3022621) pH of Urine by Test strip
76
770
0.99
0.02
4.3
3.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
298
0.97
0.02
1.8
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
116
1.03
0.00
1.4
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
112
0.98
0.00
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
43
429
1.00
0.00
1.9
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
35
347
1.01
0.00
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
24
245
0.98
0.00
1.6
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
175
0.97
0.00
1.2
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.6
—
0
5
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
15.5
—
0
7
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.7
—
2.3
—
0
6
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
98
0.92
0.00
1.2
1.2
nmol/l
1.7
1.4
—
9
83
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
37.9
—
0
9
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
3.0
—
0
6
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
67
0.90
0.00
1.5
1.2
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
20.6
—
0
9
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
5
59
0.85
0.00
7.6
4.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
54
0.93
0.00
7.6
4.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
7.9
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint E4_HYPOPARA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_HYPOPARA | 1.606 [1.43, 1.81] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.323 |
During the follow-up period (1.1.1998 — 31.12.2019), 1113 out of 4177 females with E4_HYPOPARA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_HYPOPARA | 2.355 [1.88, 2.95] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.022 |
During the follow-up period (1.1.1998 — 31.12.2019), 395 out of 1066 males with E4_HYPOPARA died.
Mortality risk
Mortality risk for people of age
years, who have E4_HYPOPARA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.192% | 0.59% |
| 5 | 1.074% | 2.882% |
| 10 | 2.494% | 7.055% |
| 15 | 4.443% | 13.555% |
| 20 | 7.481% | 22.969% |
Relationships between endpoints
↥Index endpoint: E4_HYPOPARA – Hypoparathyroidism
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data